Critics argue Tesla's push to build its own AI chips is a costly distraction from core revenue drivers like robotaxis. With the stock trading at a premium valuation, analysts question if the company is prioritizing long-term tech over near-term profits.
Tesla (NASDAQ: TSLA) is facing renewed scrutiny from investors who argue that its aggressive push to manufacture its own artificial intelligence chips is a negative distraction from more immediate, high-revenue opportunities. While the electric vehicle maker has long been associated with automotive innovation, its recent strategic pivot toward becoming an AI and robotics company has led to significant capital allocation debates. Critics contend that resources are being diverted from scaling proven revenue streams, such as its robotaxi fleet and humanoid robot initiatives, toward a complex and unproven semiconductor manufacturing effort.
The centerpiece of this strategy is "Terafab," a massive AI chip manufacturing complex first unveiled by CEO Elon Musk in March 2026. According to recent reports, Tesla intends to build and operate the facility itself rather than relying on established foundries like Taiwan Semiconductor Manufacturing Co. This move aims to give Tesla full control over the silicon used in its Full Self-Driving (FSD) software, Cybertruck robotaxis, and Optimus robots. Proponents argue that owning the supply chain would allow for silicon optimized specifically for Tesla’s power limits and autonomous driving workloads, reducing dependence on external suppliers.
However, skeptics point to the immense technical and financial hurdles involved. Building an advanced semiconductor fab requires expertise in process control and clean-room manufacturing that Tesla does not currently possess. Musk has acknowledged that the company does not yet know how to make microchips, a admission that has raised concerns about execution risk. The timeline for such a facility is measured in years, meaning Tesla would likely need to continue relying on external suppliers while funding the new plant, creating a "worst of both worlds" scenario if delays occur.
Financially, the project adds pressure to an already steep capital-spending bill. Tesla expects to spend more than $25 billion this year, its largest ever, and management has conceded that additional funding may be required. With the stock trading near $375 and a price-to-earnings ratio exceeding 300, analysts argue the market has priced in near-flawless execution. Gary Black, a prominent investor, has questioned the strategy, noting that the autonomous robotaxi fleet remains "stuck" at around 90 to 100 vehicles, suggesting that the company's valuation is not yet supported by tangible operational scale in its most hyped sectors.
Despite the criticism, Tesla shares have risen approximately 25% since the end of July, driven by enthusiasm for its AI narrative and recent product reveals, including a redesigned Roadster featuring SpaceX thruster technology. Nevertheless, the debate over whether Tesla is a visionary AI company or a distracted automaker remains central to its investment case as it approaches its October 21 earnings report.